miR-181a Post-Transcriptionally Downregulates Oncogenic RalA and Contributes to Growth Inhibition and Apoptosis in Chronic Myelogenous Leukemia (CML). This evidence concerns the gene RALA and chronic myelogenous leukemia, BCR-ABL1 positive.